← Back to guidelines
Anesthesiology109 papers

Neonatal agitation

Last edited: 4/14/2026

Overview

Neonatal agitation refers to heightened irritability and restlessness in newborns, often requiring prompt clinical intervention to ensure safety and comfort. Effective management involves rapid assessment and appropriate pharmacological or non-pharmacological interventions 15.

Diagnosis

  • Clinical Presentation: Irritability, crying, difficulty soothing, and signs of distress 15.
  • Ruling Out Organic Causes: Essential before attributing agitation to functional causes; consider hypoglycemia, hypocalcemia, infections, and metabolic disorders 15.
  • Neurological Assessment: Evaluate for signs of neurological distress or abnormalities 15.
  • Management

  • First-Line Treatments:
  • - Non-Pharmacological: Ensure comfort, maintain environmental stability, and consider parental presence 15. - Pharmacological: Limited specific neonatal data; extrapolate from adult guidelines cautiously.
  • Adjunctive Treatments:
  • - Ketamine: Used in pediatric settings for severe agitation; dose and safety profiles vary 68. - Midazolam-Droperidol Combination: Effective for sedation in adults; consider similar use cautiously in neonates 5. - Olanzapine: Emerging use in adults with agitation; potential for future neonatal applications 9.

    Special Populations

  • Pediatrics: Specific dosing and safety profiles for ketamine and other sedatives are extrapolated from pediatric studies 68.
  • Elderly: Not directly applicable; however, caution with drug metabolism and side effects is advised when considering analogous geriatric principles 11.
  • Key Recommendations

  • Prioritize Non-Pharmacological Interventions to soothe agitated neonates before considering medication 15.
  • Thoroughly Evaluate for Organic Causes before attributing agitation to functional factors 15.
  • Use Ketamine with Caution in severe cases, considering dose and safety profiles from pediatric studies 68 (Evidence: Moderate).
  • Monitor Vital Signs Closely during pharmacological sedation to manage potential adverse effects 9 (Evidence: Moderate).
  • Consider Parental Involvement in calming techniques as part of supportive care 15 (Evidence: Expert opinion).
  • References

    1 Kumar A, Ryus CR, Carreras Tartak JA, Nath B, Faustino IV, Shah D et al.. Association between patient primary language, physical restraints, and intramuscular sedation in the emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2025. link 2 Sullivan N, Chen C, Siegel R, Ma Y, Pourmand A, Montano N et al.. Ketamine for emergency sedation of agitated patients: A systematic review and meta-analysis. The American journal of emergency medicine 2020. link 3 Muir-Cochrane E, Oster C, Gerace A, Dawson S, Damarell R, Grimmer K. The effectiveness of chemical restraint in managing acute agitation and aggression: A systematic review of randomized controlled trials. International journal of mental health nursing 2020. link 4 Tian LL, Newman WJ. Psychiatric Considerations Regarding Prehospital Administration of Ketamine for Agitation. The Journal of nervous and mental disease 2019. link 5 Taylor DM, Yap CYL, Knott JC, Taylor SE, Phillips GA, Karro J et al.. Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial. Annals of emergency medicine 2017. link 6 Riddell J, Tran A, Bengiamin R, Hendey GW, Armenian P. Ketamine as a first-line treatment for severely agitated emergency department patients. The American journal of emergency medicine 2017. link 7 Isenberg DL, Jacobs D. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment. Prehospital and disaster medicine 2015. link 8 Pritchard A, Le Cong M. Ketamine sedation during air medical retrieval of an agitated patient. Air medical journal 2014. link 9 Wilson MP, MacDonald K, Vilke GM, Feifel D. Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients. The Journal of emergency medicine 2012. link 10 Chan EW, Taylor DM, Knott JC, Kong DC. Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments. Emergency medicine Australasia : EMA 2011. link 11 Peisah C, Chan DK, McKay R, Kurrle SE, Reutens SG. Practical guidelines for the acute emergency sedation of the severely agitated older patient. Internal medicine journal 2011. link 12 Lee YC, Kim JM, Ko HB, Lee SR. Use of laryngeal mask airway and its removal in a deeply anaesthetized state reduces emergence agitation after sevoflurane anaesthesia in children. The Journal of international medical research 2011. link 13 Knott JC, Taylor DM, Castle DJ. Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department. Annals of emergency medicine 2006. link 14 Shale JH, Shale CM, Mastin WD. A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients. The Journal of clinical psychiatry 2003. link 15 Young GP. The agitated patient in the emergency department. Emergency medicine clinics of North America 1987. link

    Original source

    1. [1]
      Association between patient primary language, physical restraints, and intramuscular sedation in the emergency department.Kumar A, Ryus CR, Carreras Tartak JA, Nath B, Faustino IV, Shah D et al. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2025)
    2. [2]
      Ketamine for emergency sedation of agitated patients: A systematic review and meta-analysis.Sullivan N, Chen C, Siegel R, Ma Y, Pourmand A, Montano N et al. The American journal of emergency medicine (2020)
    3. [3]
      The effectiveness of chemical restraint in managing acute agitation and aggression: A systematic review of randomized controlled trials.Muir-Cochrane E, Oster C, Gerace A, Dawson S, Damarell R, Grimmer K International journal of mental health nursing (2020)
    4. [4]
      Psychiatric Considerations Regarding Prehospital Administration of Ketamine for Agitation.Tian LL, Newman WJ The Journal of nervous and mental disease (2019)
    5. [5]
      Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial.Taylor DM, Yap CYL, Knott JC, Taylor SE, Phillips GA, Karro J et al. Annals of emergency medicine (2017)
    6. [6]
      Ketamine as a first-line treatment for severely agitated emergency department patients.Riddell J, Tran A, Bengiamin R, Hendey GW, Armenian P The American journal of emergency medicine (2017)
    7. [7]
    8. [8]
      Ketamine sedation during air medical retrieval of an agitated patient.Pritchard A, Le Cong M Air medical journal (2014)
    9. [9]
      Potential complications of combining intramuscular olanzapine with benzodiazepines in emergency department patients.Wilson MP, MacDonald K, Vilke GM, Feifel D The Journal of emergency medicine (2012)
    10. [10]
      Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments.Chan EW, Taylor DM, Knott JC, Kong DC Emergency medicine Australasia : EMA (2011)
    11. [11]
      Practical guidelines for the acute emergency sedation of the severely agitated older patient.Peisah C, Chan DK, McKay R, Kurrle SE, Reutens SG Internal medicine journal (2011)
    12. [12]
    13. [13]
    14. [14]
    15. [15]
      The agitated patient in the emergency department.Young GP Emergency medicine clinics of North America (1987)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG